LXT34
LXT34 (Example 2) is a GPR120 agonist. LXT34 has an anti-inflammatory activity. LXT34 promotes GLP-1 formation in the gastrointestinal tract and improves insulin resistance in macrophages and pancreas cells. LXT34 can be used for inflammatory diseases, such as type 2 diabetes, obesity and non-alcoholic fatty liver research[1].
Product Specifications
CAS Number
[1609286-95-4]
UNSPSC
12352005
Target
Free Fatty Acid Receptor; GLP Receptor
Related Pathways
GPCR/G Protein
Field of Research
Inflammation/Immunology
Smiles
O=C(CCC1=CC=C(C=C1)OCC2=CC=CN=C2SC(C)C)O
Molecular Formula
C18H21NO3S
Molecular Weight
331.43
References & Citations
[1]Kim Y K, et al. Thioaryl derivatives as gpr120 agonists. WO2014069963A1. 2014-05-08. |[2]Kim Y K, et al. Thioaryl derivatives as gpr120 agonists. WO2014069963A1. 2014-05-08.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-176838/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
